PRIVATE EQUITY - REAL ASSETS - MANAGED ACCOUNT PLATFORM
Sciens Data Room: Terms of Use

Legal Disclaimer


NOTICE: PLEASE READ THE TERMS AND CONDITIONS CAREFULLY. BY ACCESSING THIS WEBSITE (THE "SITE") YOU ACKNOWLEDGE AND AGREE TO BE BOUND BY THESE TERMS AND CONDITIONS. IF YOU DO NOT AGREE TO THESE TERMS, DO NOT ACCESS THIS SITE.

TERMS OF USE AND LEGAL INFORMATION

DISCLOSURES FOR ALL PERSONS ACCESSING THIS SITE



Purpose of the Site: The material set out on this website is for the purpose of providing information about Sciens Capital Management LLC, Sciens Fund of Funds Management Ltd. and their related companies (collectively "Sciens") and about alternative investment strategies. It is not and should not be construed as a solicitation, offer or recommendation to acquire or dispose of any investment or to engage in any investment business. Responsibility for Information: The information on this Site has been obtained from both internal and external sources. While Sciens makes every effort to ensure that the information or opinions contained on this website is accurate, reliable and complete, it makes no representation that this is in fact the case. The information is subject to change without notice. The information contained on this website does not constitute investment, legal, tax or other advice and should not be construed as such. It should not be relied upon in making an investment or other decision. Sciens reserves the right to change the terms, conditions and notices under which this Site is offered. Limitations of Liability: Sciens will not be liable for any loss or damage of any kind howsoever arising, including (without limitation) any direct, special, indirect or consequential damages, even if Sciens, or another company within one of the Sciens business groups, has been expressly advised of the possibility of such loss or damage, arising out of or in connection with the access (or inability to access) or use of this Site. No Warranty: The Site, including information and materials contained in the Site, text, graphics, software, links and other items are provided "as is" and "as available". Sciens does not warrant the accuracy, adequacy, completeness, timeliness or availability of the Site, and expressly disclaims liability for errors or omissions in the web site. There is no warranty of merchantability, no warranty of fitness for a particular purpose, no warranty of non-infringement, no warranty of any kind, implied, express or statutory, in conjunction with the web Site. Copyright: The information on this Site is the copyright of Sciens and no information may be reproduced in any form, other than for the purpose of making copies for their own use by permitted users of this Site, without the prior written permission of Sciens. All rights are reserved. The Site and any and all accompanying screens, information, materials, user documentation user interfaces, images, arrangements of information, related software and other proprietary property of Sciens or its licensors accessible via the Site is and shall remain the exclusive property of Sciens and its licensors, as the case may be. The name "SCIENS" is copyrighted. Unauthorized Access: This Site is not absolutely protected against unauthorized third parties. You acknowledge that any information provided through the Internet may be potentially accessed by unauthorized third parties. Although Sciens will make reasonable efforts to protect the privacy of users of this Site, no guarantee can be made that unauthorized third parties will not access the information contained on the Site. You acknowledge that Sciens is not responsible for notifying you that unauthorized third parties have gained such access or that any data has been otherwise compromised during transmission across computer networks or telecommunications facilities, including, but not limited to, the Internet. Passwords and Security: You are responsible for the confidentiality and use of your password. Your password is an important means of protection for you. You agree to contact us immediately if you believe that an unauthorized person has obtained access to your password. Links: Sciens makes no representations whatsoever about the opinions of any third party appearing on a linked site, neither regularly monitors nor has control over the contents of such sites and does not endorse, and disclaims all responsibility for, the content of such statements or websites. Privacy Policy: Sciens will not disclose Investors' Non-Public Personal Information or that of any former clients to third parties other than (i) Affiliates and/or (ii) other third party firms that assist Sciens in providing advisory services and/or effecting client transactions (such as brokers, fund administrators, accounting support firms and compliance/operational support service providers) or (iii) except as may be required by law or regulation. Additionally, Sciens' disposal of Non-Public Information shall be done in a secure manner. Performance: PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RETURNS. Any information you receive from the Site does not necessarily reflect the most up to date or current information available on the fund, product or service provided by Sciens. DISCLOSURES FOR US INVESTORS Availability: AS REQUIRED BY THE U.S. SECURITIES AND EXCHANGE COMMISSION, THIS PASSWORD-PROTECTED SITE MAY ONLY BE ACCESSED BY EXISTING CLIENTS OF SCIENS AND PROSPECTIVE CLIENTS OF SCIENS WHO, AMONG OTHER REQUIREMENTS, ARE QUALIFIED AS ACCREDITED INVESTORS OR WHO GENERALLY ARE SOPHISTICATED IN FINANCIAL MATTERS SUCH THAT THEY ARE CAPABLE OF EVALUATING THE MERITS AND RISKS OF PROSPECTIVE INVESTMENTS. Offerings: THE INFORMATION ON THIS SITE IS NOT AN OFFER TO SELL OR SOLICITATION OF AN OFFER TO BUY AN INTEREST IN ANY INVESTMENT FUND OR FOR THE PROVISION OF ANY INVESTMENT MANAGEMENT OR ADVISORY SERVICES. ANY SUCH OFFER OR SOLICITATION WILL BE MADE ONLY BY MEANS OF A CONFIDENTIAL PRIVATE OFFERING MEMORANDUM RELATING TO A PARTICULAR FUND OR INVESTMENT MANAGEMENT CONTRACT AND ONLY IN THOSE JURISDICTIONS WHERE PERMITTED BY LAW. Sciens offers investment opportunities through both domestic funds and offshore funds. Offshore offerings are made in accordance with Regulation S under the Securities Act of 1933 and Sciens may concurrently make offerings to U.S. persons (generally tax-exempt persons) in accordance with Regulation D under the Securities Act of 1933. To ensure that an offshore offering is not targeted at the general U.S. audience and to ensure that an offshore offering is not used as a general solicitation or advertisement for the U.S. offering in violation of Regulation D, you are required to provide Sciens with certain information regarding your residency and investor accreditation. Upon providing Sciens with this information, you will be issued a password which will enable to you view applicable sections within the Site. Further, in accessing this Site by clicking on the acceptance box below, you will be representing and warranting to Sciens that you are not breaching and that you are not causing Sciens to breach any of those restrictions by your accessing this Site. Sciens will rely on your representations and warranties. DISCLOSURES FOR UK INVESTORS The information on this website has been approved for publication in the UK by Sciens Capital Limited (SCL), which is authorised and regulated by the Financial Services Authority to conduct investment business in the UK. Availability: The funds referred to on this website are not registered with or authorized by the Financial Services Authority and as such they are all authorized collective investment schemes ("Unrecognised Schemes"). Section 238 of the Financial Services and Markets Act 2000 and the Financial Services and Markets Act 2000 (Promotion of Collective Investment Schemes) (Exemptions) Order 2001 (SI 2001/1060) prohibits the promotion of authorized collective investment schemes to persons in the United Kingdom ("UK Investors") except to the following types of persons ("Eligible Investors"):- a. Persons authorized to conduct investment business in the UK and investment firms from other Member States of the European Union authorized to establish a branch or provide services in the UK; b. A government, local authority or public authority; c. Any body corporate which has a called up share capital or net assets of: (i) not less than £500,000, where the body corporate has more than 20 members or is a subsidiary of such a parent; (ii) not less than £5 million, in the case of any other body corporate; d. Any unincorporated association or partnership which has net assets of not less than £5 million; e. The trustee of a high value trust (a trust whose aggregate value of cash and investments forming part of the Trust's assets before deducting liabilities is £10 million or more, or has been £10 million or more at any time during the last twelve months); f. Any person whilst acting in the capacity of director, officer or employee of the entities described in (a) to (e) above; g. Certified Sophisticated Investors; h. Associations of people in (a) to (g) above; i. Authorised persons acting as uthori or grantor of a trust, a trustee or a personal representative, or a trustee of the trust, a fellow trustee or a fellow personal representative acting in such capacity when viewing this website; j. Authorised persons acting as uthori of a trust, trustee or personal representative to a beneficiary under the trust, will or intestacy, or an authorized person who is a beneficiary under a trust, will or intestacy communicating with another beneficiary under the same trust, will or intestacy acting in relation to the management or distribution of that trust, fund or estate when viewing this website; k. Investment journalists (i.e. persons who receive a communication in the course of a business which involves the dissemination through a publication of information concerning investments); or l. Existing customers of any of the funds. This Site is not intended for UK Investors other than those persons specified above, who are Eligible Visitors. Access to this website is limited only to Eligible Visitors. A UK Investor seeking to purchase funds from affiliates of Sciens will have to demonstrate that they fall into one of the above categories (other than k). In accessing this Site by clicking on the acceptance box below, you will be representing and warranting to Sciens that you are not breaching and that you are not causing Sciens to breach any of those restrictions by your accessing this website. Sciens will rely on your representations and warranties. Further, to ensure that only Eligible Investors have access to this Site, UK Investors are required to provide Sciens with certain information regarding your residency and investor accreditation. Upon providing Sciens with this information, you will be issued a password which will enable to you view applicable sections within the Site. DISCLOSURES FOR OTHER INVESTORS Availability: The information provided on this Site is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Sciens to any registration requirement within such jurisdiction or country. To use this Site, you must be a resident of or located in a jurisdiction where the distribution, publication or provision of the information and content of this site may be lawfully provided or offered. In accessing this Site by clicking on the acceptance box below, you will be representing and warranting to Sciens that you are not breaching and that you are not causing Sciens to breach any of those restrictions by your accessing this website. Sciens will rely on your representations and warranties. To ensure that only qualified investors have access to this Site you are required to provide Sciens with certain information regarding your residency and investor accreditation. Upon providing Sciens with this information, you will be issued a password which will enable to you view applicable sections within the Site. ASSISTANCE If you need assistance with the Site, or if you need to communicate with Sciens, you may telephone or write to: For US Investors: Christopher P. Meyering (New York) cmeyering@scienscapital.com +1 212 471 6100 For UK or Other Investors: Douglas Sharp (London) dsharp@sciensam.com +44 20 7078 0618 The services described on this web site may not be available in all jurisdictions or to all persons. For further detail, please see our Terms of Use. All rights reserved. © 2010 Sciens Capital Management LLC
The services described on this web site may not be available in all jurisdictions or to all persons. For further detail, please see our Terms of Use. All rights reserved.
© 2020 Sciens Capital Management LLC